Heme Oxygenase-1 as a Predictor of Early Allograft Dysfunction in Liver Transplantation: A Prospective Observational Pilot Study
Peri-implantation HO-1 kinetics may represent a novel biomarker of EAD. Larger validation studies and mechanistic investigations are warranted to refine risk stratification and guide targeted interventions to mitigate EAD.
Authors
- Craig M. Coopersmith (ORCID: https://orcid.org/0000-0003-2400-3217)
- Anna Woodbury (ORCID: https://orcid.org/0000-0003-0644-6049)
- Craig S. Jabaley (ORCID: https://orcid.org/0000-0001-6687-3953)
- Elizabeth A. Wilson (ORCID: https://orcid.org/0000-0002-8105-0928)
- Kirsten M. Williams
- OXIDATIVE Study Group
- Andrew S. Barbas
- Ammar Rashied
Institutions
- Apple (Israel) (IL)
- Emory University (US)
- Advisory Board Company (United States) (US)
- Duke Medical Center (US)
- Children's Healthcare of Atlanta (US)
- The Stables (GB)
Publication Details
- Journal
- Transplantation Direct
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1097/txd.0000000000001909
- Primary Topic
- Heme Oxygenase-1 and Carbon Monoxide
- Type
- article
- Field-Weighted Citation Impact
- 0.00